explore -WSS

explore

author：entertainment 2025-09-27 12:13:06 - browse：443

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Biogen walks away from Aduhelm, years after polarizing approval

focus

WSS

Zyn nicotine pouches become unlikely player in latest culture war

FTC sues over Novant Health acquisition of two N.C. hospitals

What drug price negotiations mean for Medicare Part D

What American doctors can learn from their Israeli counterparts

Covid hospitalizations on the rise, Humana says

Bernie Sanders is gearing up to subpoena pharma CEOs

explore

explore

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Syphilis numbers in the United States reach record heights

Hollywood unions extend contract negotiations for actors

ALS advocates say criticism of new drugs misses bigger picture

Peter Hotez and the public health issue of online harassment

ALS advocates say criticism of new drugs misses bigger picture

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Hepatitis C has a cure — but many Americans still lack access to it

Philips to halt sales of sleep apnea machines in U.S.

entertainment

Philips to halt sales of sleep apnea machines in U.S.

Why Novartis is changing the name of its research labs

Bernie Sanders is gearing up to subpoena pharma CEOs

Medicare drug price negotiation legal challenge met with skepticism

'Make People Better': The CRISPR babies story you probably don't know

Why Novartis is changing the name of its research labs

hotspot

focus

hotspot

entertainment